) Q1/FY2020 Q1/FY2019 change %YoY Total Revenues 1,245.17 1,439.49 (194.32) -13.50% Cost of Sales and Services 1,074.00 1,251.00 (177.00) -14.15% Selling and Administrative Expenses 99.63 103.61 (3.98
) (10.27) Cost of sales and services (4,469) (4,509) 40 (0.88) Gross profit 516 1,047 (531) (50.72) Profit (loss) for the period (512) 272 (783) (288.38) Gross profit margin (%) 10 19 (9) (45.3) Profit (loss
well as attending Chinese fertility centers which is the main user group of the subsidiary company. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of THB
30,006 30,283 -277 -0.91% Other income 4,080 12 4,068 33900.00% Total revenues 57,229 45,772 11,457 25.03% Cost of sales of goods or of services -26,891 -27,709 818 -2.95% Selling expenses -1,961 -356
, decrease 14.94 million baht from the same period last year or 65.38% ,this was the result from quarter 1 in 2019 other income occurs from the acquisition cost of PEI’s shares was approximately Baht 10.39
% Entertainment 11.13 5% - - 11.13 n.a. Total Revenue 227.64 100% 276.43 100% (48.79) -18% Total Cost 130.61 57% 158.68 57% (28.07) -18% Gross profit 97.03 43% 117.75 43% (20.72) -18% Other Revenues & Profit
), Investment Property The Company changes the measurement of the investment property from cost model to fair value model retrospectively (full retrospective approach). Changes in accounting policies: Thai
service channels providing more convenience to customers and this also saved the Company’s operation cost. For the Cardless transactions currently accounted for 25% of total personal loan sales. Total Sales
weak global demand, especially exports of Epichlorohydrin decreased caused by lockdown restrictions in several countries. Analysis of Cost and Expenses 1. In Q2 2020, Cost of sales was 2,898 MTHB
2020, the net profit of the Company and its subsidiary was 443.50 million baht. The total income was 1,046.19 million baht, financial cost was 286.71 million baht, the selling and administrative expense